ȕ1-integrin induction enhances breast cancer cell survival after exposure to ionizing radiation (IR), but the mechanisms of this effect remain unclear. Although NF-κB initiates prosurvival signaling pathways post-IR, the molecular function of NF-κB with other key elements in radioresistance, particularly with respect to extracellular matrix-induced signaling, is not known.
Introduction

Results
NF-țB inhibition sensitizes human malignant breast cancer T4-2 cells to ionizing radiation.
We have previously shown that malignant T4-2 colonies are significantly more resistant to radiation-induced death compared to non-malignant counterpart S1 acinar structures in 3D lrECM (13). We used clonogenic survival assays to verify that malignant T4-2 cells indeed had increased reproductive capacity compared to S1 cells post-IR (Fig. 1A) . In addition, ȕ1-integrin inhibition by AIIB2 monoclonal antibody increased radiosensitivity in T4-2 cells (Fig. 1B) . It is well documented that NF-țB is activated by IR and plays a central role in radiation resistance (23, 29) . The activity of NF-țB is largely regulated by its subcellular localization. Using immunoflourescence for p65 (a major subunit of NF-țB), we measured the effect of IR on the activation of NF-κB in T4-2 and S1 cells in two-dimensional (2D) monolayer culture. In S1 cells, 4-Gy IR rarely induced nuclear translocation of p65. In contrast, nuclear p65 was observed in 8.6% of Sham irradiated T4-2 cells and 59% of T4-2 cells exposed to 4Gy at 4 hr ( Fig. 1C and inhibition of NF-țB activity should increase radiosensitivity. To test this, NF-țB activity was inhibited by 4-Methyl-N¹-(3-phenylpropyl)benzene-1,2-diamine (JSH-23) and then colony formation assay was performed. As shown in Fig. 1B , JSH-23 resulted in a significant decrease in surviving clones. Overall, these findings demonstrate that ȕ1-integrin is a novel target of NF-țB in radioresistance of breast cancer cells, but not non-malignant human mammary epithelial cells.
NF-țB activation is required for radiation-induced ȕ1-integrin overexpression.
In a 3D laminin-rich ECM (lr-ECM)-based cell culture model ( Fig. 2A ; experimental schema), which better mimics physiological growth conditions than 2D cultures (8, 30-32), malignant breast cancer T4-2 cells showed higher levels of total and phospho (T788/789) ȕ1-integrins compared to its counterpart non-malignant S1 cells (Fig. 2B ). These protein levels were further induced in T4-2 cells post-IR (4-Gy x-ray; Fig. 2C ). Interestingly, treatment of T4-2 colonies, formed at day 4, with NF-țB inhibitors JSH-23 or IMD-0354 resulted in a decrease in phospho and total ȕ1-integrins, which was further reduced by IR ( Fig. 2C and Supplementary Fig. S1A ).
At 30 μM concentration of JSH-23, which selectively blocks nuclear translocation of NF-țB p65 and its transcription activity, both phospho and total ȕ1-integrins were significantly reduced independently of radiation exposure. (Fig. 2C) . IMD-0354, an IKK-ȕ inhibitor that blocks IțB-Į phosphorylation and NF-țB availability, also significantly reduced phospho and total ȕ1-integrins by 5 μM and 10-20 μM, respectively with or without IR ( Supplementary Fig. S1A ).
Similarly, IR-induced increases in ȕ1-integrin mRNA expression were significantly reduced by JSH-23 in a dose-dependent manner (Fig. 2D) . To confirm inhibition of ȕ1-integrin activity, phosphorylation of FAK397, a critical indicator of downstream ȕ1-integrin signaling, was measured. As shown in Supplementary Fig. S1B , inhibition of ȕ1-integrin by NF-țB inhibitor JSH-23 significantly reduced the levels of total and phosphorylated FAK. These results clearly show that IR-induced ȕ1-integrin expression and its downstream signaling are mediated by NF-țB. Similar to ȕ1-integrin, protein levels of p65/p50, the major inducible NF-țB dimer, were also higher in T4-2 than S1 cells (Fig. 2B) . We prepared whole cell lysates for immunoblotting of p65 and p50 to determine if NF-țB transactivation following IR was associated with an increase in p65/p50 levels. Compared to Sham (0 Gy) IR control cells, a clear increase in p65/p50 was observed post-IR; in addition, these levels were decreased by JSH-23 in a dosedependent manner (Fig. 2E) . Together with Fig. 2C , these results indicate that NF-țB and ȕ1-integrin are components of a coordinated response to radiation.
Next, we asked whether transcriptional activity directed through NF-țB was involved in the upregulation of ȕ1-integrin post-IR. To determine this, we performed an ELISA-based DNA binding assay in 3D lrECM to quantify the binding of NF-țB to its binding site identified in the ȕ1-integrin promoter (Fig. 1F) . A 50 bp oligo containing the țB binding site on the ȕ1-integrin promoter region was synthesized and then used as a DNA probe to assess binding of IR-activated NF-țB in T4-2 and S1 cells. As shown in Fig. 2F , NF-țB DNA binding activity was much higher (~ 4-fold) in T4-2 compared to S1 cells and 4-Gy x-ray significantly increased binding activity. However, the binding activities were not induced with or without radiation when a 50 bp DNA probe containing a mutation in the țB site was used. To test the generalizability of these results, the induction of DNA binding activity of NF-țB observed in T4-2 cells post-4-Gy x-ray was confirmed in another cell line ( Supplementary Fig. S1B ). Similar to T4-2 cells, binding activities were significantly increased (~ 3.8-fold) post-IR in human malignant breast cancer MDA-MB-231 cells. As expected, this induction of DNA binding of NF-țB was abolished when the mutated probe was used. Together, these data identified ȕ1-integrin as a downstream transcriptional target of NF-țB in 3D lrECM T4-2 cell cultures.
Inhibition of NF-țB activity reduces colony size via increasing apoptosis and decreasing proliferation in malignant breast cancer colonies in 3D lrECM.
We showed previously that inhibition of ȕ1-integrin by monoclonal antibody AIIB2 significantly increased TUNEL-positive nuclei and decreased Ki-67-positive nuclei in a panel of malignant breast cancer colonies (28). Fig. 2 shows that NF-țB positively regulates ȕ1-integrin, which suggests that NF-țB inhibition may reduce the colony size via increasing apoptosis and decreasing proliferation in malignant breast cells. To test this hypothesis, malignant T4-2 colonies and nonmalignant S1 acini on top of 3D lrECM gels with 5% Matrigel formed at day 4 and 6, respectively, were treated with NF-țB inhibitor JSH-23 and then exposed to sham or a single dose of 4-Gy x-ray 24 h post-treatment. Upon NF-țB inhibition, T4-2 colony size was significantly reduced at 48 h. IR further reduced the size in a dose-dependent manner (data for 20 and 30 μM were not shown; Fig. 3A and B) . The maximum size difference was reached in colonies treated with 40 μM JSH-23 and exposed to IR, associated with a substantial ~40% decrease in the average colony diameter. In contrast, the average diameter of S1 acini was only marginally reduced by 20 μM -40 μM JSH alone, and no further reduction was observed by the addition of IR (data for 10 and 30 μM were not shown; Supplementary Fig. S3A and B) . but not in malignant cells. As we have shown previously (8), the interaction of ȕ1-integrin with one of its heterodimeric partners Į5-integrin was almost absent in S1, but very high in T4-2, cells without radiation. Although IR slightly induces Į5ȕ1-integrin complex in both S1 and T4-2 cells, the level of interaction was much higher in T4-2 than S1 cells post-IR (Supplementary Fig. S4C ; marked with arrows). Together with Supplementary Fig. S4A and B, these results suggest that the induction of physical interaction of ȕ1-integrin with Į5-integrin, but not with p65, promotes radioresistance in malignant breast cancer cells in 3D lrECM. The exact mechanism underlying the interaction of ȕ1-integrin with p65 and Į5-integrin in radiosensitivity is the subject of ongoing investigations.
Inhibition of NF-țB activity results in tumor growth inhibition in vivo associated with downregulated ȕ1-integrin expression.
To test if the in vitro observations in 3D lrECM culture could be validated in vivo, we examined tumor growth from mice injected with vehicle or NF-țB-inhibited T4-2 cells exposed to sham or 4-Gy x-ray. As shown in the tumor growth curves ( Fig. 5A and B) , NF-țB inhibition by 20 μM of JSH-23 in T4-2 cells (T4+JSH) significantly delayed the growth of tumors relative to control in athymic mice. We also found that tumors exposed to IR post-JSH-23 treatment (T4+JSH+IR) grew dramatically slower than control. The significant suppression of tumor formation was observed at day 13 after a subcutaneous injection of T4+JSH or T4+JSH+IR cells and continued till the day of sacrifice (day 28).
We next tested the expression levels of ȕ1-integrin and NF-țB p65 by immunohistochemical staining (Fig. 5C ). As seen in the representative tissue sections, ȕ1-integrin was reduced in T4+JSH tumors and a severe reduction was observed in tumors formed by T4+JSH+IR.
Similarly, total and nuclear NF-țB p65 were also reduced in T4+JSH and a further reduction was observed in T4+JSH+IR tumors. Then, Western blot analysis of tumor sections was performed to 
further determine the expression levels of ȕ1-integrin and NF-țB. The Western data also revealed a decrease in phospho and total ȕ1-integrins together with p65/p50 in NF-țB-inhibited T4-2 tumors, which was further reduced by IR (Fig. 5D) . The results of these experiments demonstrate that NF-țB inhibition in T4-2 cells with or without IR decreases the tumor growth via inhibition of ȕ1-integrin expression in athymic mice. Together with Fig. 2 C-F , the data in (Fig. 6B) . Together with Fig. 1B and 2C and F, these results suggest a loop-like ȕ1-integrin-NF-țB-ȕ1-integrin pathway is activated post-IR to induce radioresistance in T4-2 cells in 3D lrECM (schematic presentation is shown in Fig. 6C ).
Research. 
Discussion
Cancer cells dynamically interact with their microenvironment to remodel the surrounding stroma and facilitate growth and invasion. Tumor extracellular matrix (ECM) has been shown to increase resistance to cytotoxic cancer therapy including radiation (6, 7) and has also been associated with poor outcomes in subgroups of breast cancer patients (34). However, the underlying basis for ECM-mediated resistance to therapy, particularly after radiation, has not been well studied. We have previously shown that targeting ȕ1-integrin leads to selective apoptosis and cytostasis in breast cancer cells in vivo without toxicity. In addition, a number of studies have shown that ȕ1-integrins regulate radiation-induced pro-survival signaling, leading to increased survivability and reproductive capacity of human cancer cells exposed to ionizing radiation (IR) (8, 9, 13, 14, 28). In the present study, we wished to further dissect the possible molecular mechanisms associated with ȕ1-integrin regulation of survival in irradiated cancer cells. We discovered that a typical NF-țB binding site was located in the promoter region of the ȕ1-integrin gene (Fig. 1F) . Given the known role of NF-țB in mediating an acute phase stress response to IR, we sought to further investigate a potential novel relationship between ECM directed signaling and ȕ1-integrin mediated survival. Here, we show that NF-țB directly modifies ȕ1-integrin expression, in part through transcriptional activation ( Fig. 2D and F) . This is associated with increased survival post-IR, and sensitization of cells to IR-induced death upon inhibition of NF-țB (Fig. 1B and 3C and D) . This pathway is functional in several breast cancer cell lines, and notably oppositely regulated in normal human mammary epithelial cells (Supplementary Fig. S3 ). Finally, inhibition of ȕ1-integrin reverses NF-țB transcriptional activity (Fig. 6B) , suggesting a loop-like ȕ1-integrin NF-țB ȕ1-integrin regulatory pathway in malignant, but not normal cells. ȕ1-integrin signaling has been shown to mediate diverse roles in cancer progression including invasion, migration and metastasis (35, 36). In addition, ȕ1-integrins mediate resistance to cytotoxic chemotherapy and radiation in several human cancers (6-9). In addition, we have previously shown that the combination of ȕ1-integrin inhibitory antibodies with IR significantly reduced the dose that was necessary to achieve the same growth inhibitory effect in breast cancer xenografts in vivo, related to regulation of Akt signaling downstream of ȕ1-integrin (8, 13).
Cordes et al. showed a FAK/cortactin-dependent regulation directly linked of ȕ1-integrinmediated survival post-IR in squamous cell carcinoma of the head and neck (9). Thus, increasing evidence indicates that inhibiting ȕ1-integrins enhance the therapeutic efficacy of radiation therapy through critical signaling pathways. However, modulation of gene expression is one of the most important events because it directly controls cellular adaptation to genotoxic conditions; yet little is known regarding the potential transcriptional mechanisms involved in the ȕ1-integrindependent survival pathway of cancer cells after IR treatment. Here, we show that IR induces p65 translocation into the nucleus (Fig. 1C and D) and concomitantly increases NF-țB binding to the ȕ1-integrin promoter region (86 bp upstream of transcription initiation site; Fig. 1E ), suggesting that IR-induced NF-țB activity transcriptionally upregulates ȕ1-integrin.
To elucidate the functional consequences of this interaction, we measured therapeutic endpoints after inhibition of NF-țB using JSH-23. We used a clonogenic assay to show that reproductive capacity was significantly reduced in JSH-23-treated malignant breast cells after IR (Fig. 1B) . In addition, since we have previously shown that using 3D lrECM accurately predicted response between normal and malignant cells in vivo, we tested JSH-23 in this context. As shown, colony size and proliferation were dramatically reduced while apoptosis was increased in T4-2 but not malignant, but not non-malignant breast cells (Fig. 3 and Supplementary Fig. S3 ). To determine 6A and B, we demonstrated that IR-induced NF-țB p65/p50 expression and DNA binding activity were inhibited by ȕ1-integrin function blocking monoclonal antibody AIIB2. This feedforward loop-like ȕ1-integrin-NF-țB-ȕ1-integrin pathway activated post-IR may cause tumor resistance. A schematic presentation of the ȕ1-integrin-NF-țB-ȕ1-integrin loop in radioresistance is proposed in Fig. 6C . We speculate that activation of this pathway results in the failure of DNA-damaging anti-cancer modalities in breast cancers.
In summary, we report here a novel finding that ȕ1-integrin is induced by exposure to radiation through NF-țB-mediated gene activation in 3D lrECM breast cancer cell culture and breast cancer xenografts. NF-țB-mediated ȕ1-integrin overexpression is tightly associated with enhanced clonogenic survival and tumor repopulation. Our results suggest that breast cancer therapy may be enhanced by targeting the NF-țB/ȕ1-integrin pathway of radiation-resistant tumors.
Research. T4-2 colonies and S1 acini formed at day 4 and 6, respectively, were treated with NF-țB activation inhibitor JSH-23 or vehicle (DMSO), and then exposed to sham or 4-Gy x-ray at day 5 (T4-2) and 7 (S1). Whole cell lysates were prepared 48 h post-IR for Western and NF-țB DNA binding assays. B, Western blot analyses on the expression of phospho and total ȕ1-integrins, and p65/p50 (major heterodimer of NF-țB) using whole lysates prepared from malignant breast cancer T4-2 and non-malignant S1 breast epithelial cells at day 7 and 9, respectively, in 3D lrECM. ȕ-actin serves as an internal loading control. C and E, Western analyses of phospho and 
